| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9320758 | European Urology Supplements | 2005 | 10 Pages |
Abstract
Tamsulosin OCAS shows improved PK compared with the standard MR capsules. Such improved PK may translate in an improvement of the efficacy/safety ratio during the treatment of LUTS/BPH. Demonstration of such potential benefits as well as the establishment of the daily dose will require subsequent confirmatory clinical studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Mirjam Kuipers,